WHEN AI TRANSPARENCY CROSSES LANGUAGES
What does EU AI Act transparency mean for global products? Explore what happens when AI disclosures have to work across languages and interfaces.
Silvia Pedraza
ICH E6(R3) ANNEX 2: WHAT IT MEANS FOR MULTILINGUAL CONTENT
What does ICH E6(R3) Annex 2 mean for multilingual clinical trials? Explore what changes for localization and how Montero can support your trial.
IS YOUR CHINESE PATENT TRANSLATION FILING-READY?
Learn what makes a Chinese patent translation filing-ready for CNIPA, from terminology consistency and claim accuracy to specialist human review.
WHY MEMES NEED TRANSCREATION, NOT TRANSLATION
Your message can be flawless and still fall flat abroad. A study on 6,000+ US and Chinese memes shows why, and how transcreation fixes it.
THE LINGUISTIC DUE DILIGENCE CHECKLIST FOR CROSS-BORDER M&A
A mistranslated clause can unravel a cross-border deal after closing. Here’s what linguistic due diligence is, and the 5-point checklist to run before signing.
BUSINESS LOCALIZATION: CHOOSING THE RIGHT LANGUAGES
A practical framework for prioritizing languages by market potential, buyer behavior, and ROI. For decision-makers planning global growth.
WHY APPROVED TEXT FAILS IN NEW SUBMISSIONS
One copied sentence can delay a regulatory launch. Here’s why approved wording can become a compliance risk in a new context.
THE HUMAN GENOME: HOW LANGUAGE SHAPES THE FUTURE OF BIOTECH IP
In genomics IP, a mistranslated claim can cost hundreds of millions. Here’s what the Human Genome Project taught us about language, patents, and legal consequences.
WHAT STAGNANT LANGUAGE COSTS A GROWING BUSINESS
Your business evolved. Did your messaging? Discover how outdated language creates friction and why translation and localization belong in your growth strategy.
WHAT THE 2026 IP LAW CHANGES MEAN FOR PATENT TRANSLATION
A compliant patent can still face objection if its translation falls short. Here’s what the 2026 IP law changes imply for cross-border filings and language services.